Pfizer Inc (PFE)
21.85 x 100 21.92 x 1,500
Post-market by (Cboe BZX)
21.91 +0.32 (+1.48%) 04/11/25 [NYSE]
21.85 x 100 21.92 x 1,500
Post-market 21.90 -0.01 (-0.05%) 19:59 ET
for Fri, Apr 11th, 2025
Results
download Want to compare other data? Select Fields| Symbol | PFE | SNY | INVA | ||
| Company | Pfizer Inc | Sanofi-Aventis S.A. ADR | Innoviva Inc | ||
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NASDAQ | ||
| Open | 21.59 | 50.58 | 17.18 | ||
| High | 22.00 | 51.80 | 17.73 | ||
| Low | 21.28 | 50.20 | 16.90 | ||
| Last | 21.91 | 51.50 | 17.52 | ||
| Change | +0.32 | +1.84 | +0.42 | ||
| % Change | +1.48% | +3.71% | +2.46% | ||
| Volume | 55,078,000 | 3,191,000 | 886,400 | ||
| 20-Day Average Volume | 68,911,758 | 2,922,740 | 1,006,375 | ||
| Previous Close | 21.59 | 49.66 | 17.10 | ||
| Industry | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 24.52 | 54.56 | 17.57 | ||
| 20-Day Raw Stochastic | 17.75% | 33.14% | 50.90% | ||
| 20-Day Relative Strength | 30.56% | 41.96% | 47.02% | ||
| Weighted Alpha | -23.40 | +7.08 | +11.19 | ||
| Today's Opinion | 100% Sell | 24% Sell | 100% Sell | ||
| Previous Opinion | 100% Sell | 24% Sell | 100% Sell | ||
| Last Month's Opinion | 100% Sell | 88% Buy | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.61% since 04/04/25 | -0.92% since 04/04/25 | -1.13% since 04/04/25 | ||
| Low | 20.92 on 04/09/25 | 47.70 on 04/09/25 | 16.67 on 04/10/25 | ||
| High | 23.16 on 04/07/25 | 52.19 on 04/07/25 | 17.89 on 04/08/25 | ||
| 1-Month | |||||
| %Chg | -15.70% since 03/11/25 | -12.33% since 03/11/25 | -0.62% since 03/11/25 | ||
| Low | 20.92 on 04/09/25 | 47.70 on 04/09/25 | 16.67 on 04/10/25 | ||
| High | 26.52 on 03/21/25 | 59.17 on 03/18/25 | 18.34 on 03/28/25 | ||
| 3-Month | |||||
| %Chg | -18.00% since 01/10/25 | +5.68% since 01/10/25 | +1.39% since 01/10/25 | ||
| Low | 20.92 on 04/09/25 | 47.70 on 04/09/25 | 16.67 on 04/10/25 | ||
| High | 27.24 on 03/10/25 | 60.12 on 03/10/25 | 19.39 on 01/27/25 | ||
| 6-Month | |||||
| %Chg | -24.86% since 10/11/24 | -6.30% since 10/11/24 | -11.52% since 10/11/24 | ||
| Low | 20.92 on 04/09/25 | 45.80 on 12/16/24 | 16.67 on 04/10/25 | ||
| High | 29.82 on 10/16/24 | 60.12 on 03/10/25 | 21.28 on 11/12/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 124,261,584 | 130,102,640 | 1,098,083 | ||
| Shares Outstanding, K | 5,671,455 | 2,526,265 | 62,676 | ||
| Annual Sales | 63,627,000,000 | 47,921,880,000 | 358,710,000 | ||
| Annual Net Income | 8,031,000,000 | 6,016,480,000 | 23,390,000 | ||
| Last Quarter Sales | 17,763,000,000 | 8,028,910,000 | 91,810,000 | ||
| Last Quarter Net Income | 410,000,000 | 492,410,000 | 20,330,000 | ||
| 60-Month Beta | 0.67 | 0.57 | 0.48 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.63 on 02/04/25 | 0.70 on 01/30/25 | 0.57 on 02/26/25 | ||
| Latest Earnings Date | 04/29/25 | 04/24/25 | 05/14/25 | ||
| Most Recent Dividend | 0.430 on 01/24/25 | 1.478 on 05/09/24 | 0.250 on 09/08/15 | ||
| Next Ex-Dividends Date | 01/24/25 | 05/09/24 | 09/08/15 | ||
| Ratios | |||||
| Price/Earnings ttm | 6.94 | 11.94 | 9.88 | ||